Stock screener

SLN

Conviction 58HealthcareScan · Thu, Sep 24, 2026

Silence Therapeutics plc (SLN) closed at $11.21 (-2.61%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 33, RS Rating 96, -27.4% from its 52-week high, +82.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SLN$11.21-2.61%
ResistanceSupportVol 14Insider sell
63 bars
10
2
Vol MA14 838.43K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Silence Therapeutics plcPHARMACEUTICAL PREPARATIONSwww.silence-therapeutics.com ↗
Price11.21
Change-2.61%
Gap-0.09%
Rel volume0.71×
Avg volume769.05K
Avg $ vol10.09M
SMA 2013.15
SMA 5012.69
SMA 2008.07
Price vs 50-11.67%
Price vs 200+38.91%
MA stackmixed
50/200 cross—
Supertrenddown · 13.61
RSI (14)33
MACD hist-0.30
MACD cross—
Stoch %K / %D4 / 8
ADX (14)26
+DI / −DI16 / 29
RSI divergence—
MACD divergence—
ATR %6.68%
ADR %5.30%
52w high15.43
52w low4.30
From 52w high-27.35%
Above 52w low+160.70%
New 52w highNo
SqueezeOff
Bollinger width31.01%
%B0.02
Donchian pos3.55%
Donchian high15.28
Donchian low11.06
AVWAP (52w high)14.39
vs AVWAP high-22.11%
AVWAP (52w low)11.40
vs AVWAP low-1.63%
OBV trendDown
Chaikin MF (20)-0.16
Today vs 20d0.71×
Avg vol (14d)838.43K
Avg vol (20d)769.05K
Avg $ vol (20d)10.09M
Market cap529.5M
RS Rating96 / 99
RS 3m (vs SPY)+7.61%
RS 6m (vs SPY)+88.12%
RS line new highNo
Trend template6/8
Technical rank63.6
1 week-11.73%
1 month-18.00%
3 months+12.10%
6 months+104.94%
1 year+117.67%
YTD+82.28%
P/E-5.98
P/B13.76
P/S947.23
P/FCF-8.50
EPS-0.6300
Div yield—
ROE-230.33%
ROA-83.27%
Debt/Eq—
Current7.42
EV/EBITDA—
Gross margin61.54%
Net margin—
Rev growth-98.71%
EPS growth-95.57%
Price target37.00
Target upside230.06%
Analyst ratingBuy
Institutional12.32%
Ent. value457.45M
Revenue0
Net income-12.27M
Gross profit0
Free cash flow-62.33M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out47.23M
Employees88
ListedTue, Sep 8, 2020
Free float18.39M
Float %38.9%
Short interest2.44M
Days to cover3.5d
Short volume57.7%
Squeeze score56 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.26 vs −$0.32
Last surprise+18.8% beat
Setup gradeC
Conviction58 / 100
Pattern quality—
Tech rank63.6 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.43
Support11.21
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLN

All disclosures →
No recent disclosed trades by Congress in SLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLN · open-market 10 sells

InsiderSideShares
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell2.79M
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell100K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell50K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell3.5K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell800K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell382K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell470.82K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell605.17K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell120K
Griffiths Richard Ian
10% owner · American Depositary Shares · 2026-08-10
Sell60K

SEC filings

EDGAR filings in SLN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.